- €34.99m
- €36.95m
- €196.71m
- 44
- 68
- 23
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 83.1 | 77.5 | 143 | 203 | 197 |
Cost of Revenue | |||||
Gross Profit | 83 | 77.3 | 96.8 | 117 | 122 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 80.4 | 75.1 | 137 | 195 | 189 |
Operating Profit | 2.71 | 2.35 | 6.07 | 8.47 | 7.38 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.64 | 2.17 | 5.61 | 7.43 | 6.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.09 | 1.64 | 4.31 | 5.81 | 4.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.09 | 1.64 | 3.67 | 5.15 | 4.06 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.09 | 1.64 | 3.67 | 5.15 | 4.06 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.015 | 0.015 | 0.033 | 0.046 | 0.035 |
Dividends per Share |